Profile data is unavailable for this security.
About the company
Akili, Inc. is a digital medicine company engaged in the development of cognitive treatments through technologies. The Company’s approach of developing and commercializing technologies is designed to directly target the physiology of the brain. Its therapeutic engines are designed to target cognitive functions with the potential to address multiple medical conditions presenting the same functional cognitive impairments. Its product, EndeavorRx, is indicated for use to improve attention function for children ages 8-17 with primarily inattentive or combined-type attention-deficit/hyperactivity disorder (ADHD), who have a demonstrated attention issue. Its product, EndeavorOTC, which is built on the same platform as EndeavorRx, nationwide without a prescription to improve attention function, ADHD symptoms and quality of life in adults 18 years of age and older with primarily inattentive or combined type ADHD. In addition, the Company has several investigator-initiated studies.
- Revenue in USD (TTM)1.95m
- Net income in USD-48.55m
- Incorporated2022
- Employees36.00
- LocationAkili Inc71 Commercial Street, Mailbox 312BOSTON 02109United StatesUSA
- Phone+1 (617) 456-0597
- Fax+1 (302) 655-5049
- Websitehttps://www.akiliinteractive.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REMSleep Holdings Inc | 175.95k | -1.80m | 24.93m | 6.00 | -- | 36.83 | -- | 141.70 | -0.0012 | -0.0012 | 0.0001 | 0.0005 | 0.0848 | 1.69 | 11.20 | -- | -86.95 | -152.40 | -108.40 | -317.98 | -411.78 | -- | -1,025.38 | -2,317.52 | 1.63 | -18.54 | 0.0673 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.67m | 28.15m | 12.00 | -- | -- | -- | -- | -1.07 | -1.07 | 0.00 | -0.0593 | 0.00 | -- | -- | 0.00 | -605.20 | -- | -- | -- | -- | -- | -- | -- | -- | -4.39 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Retractable Technologies Inc | 40.20m | -7.80m | 28.16m | 148.00 | -- | 0.2832 | -- | 0.7006 | -0.2607 | -0.2607 | 1.34 | 3.33 | 0.2175 | 1.54 | 5.85 | 271,589.10 | -4.10 | 12.45 | -4.30 | 14.51 | 20.25 | 40.82 | -18.84 | 18.09 | 8.18 | -2.90 | 0.0145 | -- | -54.02 | 5.55 | -249.46 | -- | 17.42 | -- |
| Femasys Inc | 1.05m | -14.90m | 28.44m | 32.00 | -- | 1.81 | -- | 27.11 | -0.8567 | -0.8567 | 0.0588 | 0.7063 | 0.0549 | 0.4939 | 8.58 | 32,785.00 | -77.93 | -- | -86.46 | -- | 65.35 | -- | -1,420.27 | -- | 8.02 | -- | 0.3057 | -- | -11.13 | -- | -25.04 | -- | -- | -- |
| Neuroone Medical Technologies Corp | 3.77m | -12.80m | 29.17m | 16.00 | -- | 7.24 | -- | 7.74 | -0.5877 | -0.5877 | 0.1679 | 0.1464 | 0.598 | 2.12 | 9.79 | 235,460.60 | -203.24 | -172.88 | -269.30 | -274.74 | 30.12 | -- | -339.86 | -674.97 | 2.21 | -- | 0.00 | -- | 62.66 | -- | -18.60 | -- | -- | -- |
| Positron Corp | 1.24m | -1.27m | 31.63m | 22.00 | -- | -- | -- | 25.57 | -0.0897 | -0.0897 | 0.0876 | -0.1109 | 0.5976 | 2.29 | 6.56 | -- | -61.35 | -224.13 | -- | -- | 32.98 | 9.85 | -102.67 | -201.87 | 0.0638 | -- | -- | -- | -10.06 | 0.2751 | 63.63 | -- | 4.36 | -- |
| Akili Inc | 1.95m | -48.55m | 32.98m | 36.00 | -- | 0.6567 | -- | 16.93 | -0.6201 | -0.6201 | 0.0249 | 0.6381 | 0.0203 | -- | 20.19 | 28,647.06 | -50.58 | -- | -57.34 | -- | 56.11 | -- | -2,492.04 | -- | -- | -25.51 | 0.1835 | -- | 419.50 | -- | -212.48 | -- | -- | -- |
| Co-Diagnostics Inc | 6.68m | -38.89m | 33.16m | 155.00 | -- | 0.4232 | -- | 4.96 | -1.32 | -1.32 | 0.2268 | 2.51 | 0.0656 | 1.14 | 4.26 | 43,083.48 | -38.19 | 5.77 | -39.93 | 6.15 | 41.34 | 82.24 | -582.36 | 10.94 | 9.90 | -- | 0.00 | 0.00 | -80.09 | 179.54 | -148.15 | -- | 101.27 | -- |
| Harvard Apparatus Regenertv Tchnlgy Inc | 160.00k | -8.08m | 35.07m | 10.00 | -- | 195.26 | -- | 219.20 | -0.5824 | -0.5824 | 0.0115 | 0.0126 | 0.0474 | -- | -- | 16,000.00 | -239.52 | -330.30 | -507.69 | -1,524.88 | 77.50 | -- | -5,053.13 | -35,138.84 | 0.2558 | -- | 0.7407 | -- | -- | -- | -44.28 | -- | -39.07 | -- |
| BioRegenx Inc | 22.24k | -571.17k | 36.35m | 10.00 | -- | -- | -- | 1,634.53 | -0.0021 | -0.0021 | 0.00008 | -0.0008 | 0.4899 | -- | -- | 2,224.00 | -1,258.22 | -- | -- | -- | 96.85 | -- | -2,568.21 | -- | -- | -13.23 | 66.29 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| Inspira Technologies Oxy BHN Ltd | 0.00 | -11.29m | 37.87m | 37.00 | -- | 5.97 | -- | -- | -0.9549 | -0.9549 | 0.00 | 0.3666 | 0.00 | -- | -- | 0.00 | -88.60 | -114.98 | -108.36 | -159.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.64 | -- | -- | -- |
| Precision Optics Corporation Inc | 19.41m | -1.64m | 39.81m | 84.00 | -- | 3.53 | -- | 2.05 | -0.2706 | -0.2706 | 3.24 | 1.86 | 1.06 | 4.30 | 4.51 | 231,098.50 | -8.98 | -6.71 | -13.18 | -10.55 | 33.65 | 33.65 | -8.43 | -5.02 | 1.05 | -8.86 | 0.1982 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| IRIDEX Corp | 49.92m | -10.94m | 39.82m | 111.00 | -- | 6.14 | -- | 0.7976 | -0.6759 | -0.6759 | 3.08 | 0.3992 | 1.33 | 2.66 | 7.42 | 449,765.80 | -29.16 | -19.54 | -47.74 | -27.46 | 40.72 | 42.67 | -21.92 | -15.45 | 1.03 | -- | 0.00 | -- | -8.96 | 4.02 | -26.81 | -- | -24.35 | -- |
| electroCore, Inc. | 18.69m | -16.47m | 41.08m | 68.00 | -- | 9.14 | -- | 2.20 | -2.85 | -2.85 | 3.13 | 0.7486 | 1.16 | 1.30 | 54.34 | 274,897.10 | -102.35 | -70.73 | -177.94 | -88.96 | 82.70 | 75.81 | -88.12 | -352.82 | 1.18 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
Data as of May 24 2024. Currency figures normalised to Akili Inc's reporting currency: US Dollar USD
36.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 31 Mar 2024 | 11.51m | 14.64% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 5.78m | 7.35% |
| Baillie Gifford & Co.as of 31 Mar 2024 | 4.67m | 5.94% |
| Suvretta Capital Management LLCas of 31 Mar 2024 | 3.84m | 4.89% |
| Comprehensive Financial Management LLC (California)as of 31 Mar 2024 | 1.06m | 1.35% |
| Wildcat Capital Management LLCas of 31 Mar 2024 | 545.30k | 0.69% |
| Longitude Investment SAas of 31 Mar 2024 | 350.00k | 0.45% |
| Geode Capital Management LLCas of 31 Mar 2024 | 288.01k | 0.37% |
| First Manhattan Co LLCas of 31 Mar 2024 | 228.30k | 0.29% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 106.35k | 0.14% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
